May help to prevent 
									progression from prediabetes  
								
  
								
									
									
									Used alone and in combination  
								
  
								
									
									
									May require caution for some
									 
									with hepatic or renal disease  
							 
							 | 
							
							 
							   | 
						
						
					
					
					A trial with oral medication therapies suggested that over a 
					period of three years prediabetes patients maintained their 
					status and normoglycemia significantly better in the 
					medication treated group when compared with placebo.[i] 
					A study of troglitazone (now off the market) suggested that 
					the preventive effect of medications may last well beyond a 
					lengthy wash-out period, suggesting the potential to prevent 
					diabetes in prediabetes patients.[ii]
					 
					
					
					Injection medications
					
					
					Now let's talk about injectable medications:
					
						
							| 
							
							 
  
							
								
								
								Used alone or in combination with other 
								medications  
							 | 
							
							 
							   | 
						
					
					
					
					Insulin therapy in type 2 diabetes is reserved for higher 
					glucose levels (>8% HbA1c, symptomatic hyperglycemia, and 
					elevated fasting or high postprandial glucose levels) and 
					for use in patients who do not achieve adequate glucose 
					control on other therapies (6.5%-8.5% despite oral 
					medication therapy), including an elevated fasting glucose 
					level. There are five main categories of injected insulin 
					therapies: rapid-acting, short-acting, intermediate-acting, 
					long-acting, and premixed. Insulin therapy is the treatment 
					of choice for patients with both diabetes and renal 
					diseases. Careful monitoring is suggested when insulin is 
					used alone or in combination with other therapies.